EXPONENT INC (EXPO) Fundamental Analysis & Valuation

NASDAQ:EXPO • US30214U1025

Current stock price

66.76 USD
+1.61 (+2.47%)
At close:
66.76 USD
0 (0%)
After Hours:

This EXPO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. EXPO Profitability Analysis

1.1 Basic Checks

  • In the past year EXPO was profitable.
  • In the past year EXPO had a positive cash flow from operations.
  • Each year in the past 5 years EXPO has been profitable.
  • EXPO had a positive operating cash flow in 4 of the past 5 years.
EXPO Yearly Net Income VS EBIT VS OCF VS FCFEXPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

1.2 Ratios

  • The Return On Assets of EXPO (13.77%) is better than 88.51% of its industry peers.
  • With a decent Return On Equity value of 26.02%, EXPO is doing good in the industry, outperforming 79.31% of the companies in the same industry.
  • The Return On Invested Capital of EXPO (14.18%) is better than 77.01% of its industry peers.
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROIC 14.18%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXPO Yearly ROA, ROE, ROICEXPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 18.35%, EXPO belongs to the best of the industry, outperforming 85.06% of the companies in the same industry.
  • In the last couple of years the Profit Margin of EXPO has declined.
  • EXPO has a better Operating Margin (20.64%) than 86.21% of its industry peers.
  • In the last couple of years the Operating Margin of EXPO has remained more or less at the same level.
  • EXPO's Gross Margin of 92.96% is amongst the best of the industry. EXPO outperforms 100.00% of its industry peers.
  • EXPO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
OM growth 3Y-9.14%
OM growth 5Y-0.23%
PM growth 3Y-2.97%
PM growth 5Y-2.47%
GM growth 3Y0.68%
GM growth 5Y-0.51%
EXPO Yearly Profit, Operating, Gross MarginsEXPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. EXPO Health Analysis

2.1 Basic Checks

  • EXPO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXPO Yearly Shares OutstandingEXPO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EXPO Yearly Total Debt VS Total AssetsEXPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 8.25 indicates that EXPO is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 8.25, EXPO belongs to the best of the industry, outperforming 91.95% of the companies in the same industry.
  • EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.25
ROIC/WACC1.6
WACC8.89%
EXPO Yearly LT Debt VS Equity VS FCFEXPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

  • EXPO has a Current Ratio of 2.69. This indicates that EXPO is financially healthy and has no problem in meeting its short term obligations.
  • EXPO has a Current ratio of 2.69. This is amongst the best in the industry. EXPO outperforms 83.91% of its industry peers.
  • EXPO has a Quick Ratio of 2.69. This indicates that EXPO is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of EXPO (2.69) is better than 83.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69
EXPO Yearly Current Assets VS Current LiabilitesEXPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. EXPO Growth Analysis

3.1 Past

  • EXPO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.89%.
  • Measured over the past 5 years, EXPO shows a small growth in Earnings Per Share. The EPS has been growing by 6.06% on average per year.
  • The Revenue has been growing slightly by 4.21% in the past year.
  • Measured over the past years, EXPO shows a small growth in Revenue. The Revenue has been growing by 7.79% on average per year.
EPS 1Y (TTM)-1.89%
EPS 3Y2%
EPS 5Y6.06%
EPS Q2Q%6.52%
Revenue 1Y (TTM)4.21%
Revenue growth 3Y4.28%
Revenue growth 5Y7.79%
Sales Q2Q%4.54%

3.2 Future

  • Based on estimates for the next years, EXPO will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.40% on average per year.
  • EXPO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.39% yearly.
EPS Next Y11.32%
EPS Next 2Y11.05%
EPS Next 3Y9.4%
EPS Next 5YN/A
Revenue Next Year10.66%
Revenue Next 2Y9.32%
Revenue Next 3Y7.39%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
EXPO Yearly Revenue VS EstimatesEXPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EXPO Yearly EPS VS EstimatesEXPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. EXPO Valuation Analysis

4.1 Price/Earnings Ratio

  • EXPO is valuated quite expensively with a Price/Earnings ratio of 32.10.
  • The rest of the industry has a similar Price/Earnings ratio as EXPO.
  • The average S&P500 Price/Earnings ratio is at 25.23. EXPO is valued slightly more expensive when compared to this.
  • EXPO is valuated quite expensively with a Price/Forward Earnings ratio of 28.83.
  • EXPO's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of EXPO to the average of the S&P500 Index (23.28), we can say EXPO is valued slightly more expensively.
Industry RankSector Rank
PE 32.1
Fwd PE 28.83
EXPO Price Earnings VS Forward Price EarningsEXPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EXPO is valued a bit more expensive than 66.67% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as EXPO.
Industry RankSector Rank
P/FCF 26.75
EV/EBITDA 23.46
EXPO Per share dataEXPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EXPO does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of EXPO may justify a higher PE ratio.
PEG (NY)2.84
PEG (5Y)5.3
EPS Next 2Y11.05%
EPS Next 3Y9.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. EXPO Dividend Analysis

5.1 Amount

  • EXPO has a Yearly Dividend Yield of 1.78%.
  • EXPO's Dividend Yield is a higher than the industry average which is at 1.72.
  • EXPO's Dividend Yield is comparable with the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.78%

5.2 History

  • EXPO has been paying a dividend for at least 10 years, so it has a reliable track record.
  • EXPO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years11
Div Non Decr Years11
EXPO Yearly Dividends per shareEXPO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • EXPO pays out 58.07% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP58.07%
EPS Next 2Y11.05%
EPS Next 3Y9.4%
EXPO Yearly Income VS Free CF VS DividendEXPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EXPO Dividend Payout.EXPO Dividend Payout, showing the Payout Ratio.EXPO Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EXPO Fundamentals: All Metrics, Ratios and Statistics

EXPONENT INC

NASDAQ:EXPO (3/20/2026, 8:00:02 PM)

After market: 66.76 0 (0%)

66.76

+1.61 (+2.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners96.85%
Inst Owner Change-0.09%
Ins Owners0.98%
Ins Owner Change3.76%
Market Cap3.29B
Revenue(TTM)582.01M
Net Income(TTM)104.84M
Analysts82
Price Target89.25 (33.69%)
Short Float %5.52%
Short Ratio5.9
Dividend
Industry RankSector Rank
Dividend Yield 1.78%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP58.07%
Div Incr Years11
Div Non Decr Years11
Ex-Date03-06
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.88%
Min EPS beat(2)3.34%
Max EPS beat(2)6.42%
EPS beat(4)4
Avg EPS beat(4)6.95%
Min EPS beat(4)3.34%
Max EPS beat(4)11.81%
EPS beat(8)7
Avg EPS beat(8)7.03%
EPS beat(12)8
Avg EPS beat(12)4.77%
EPS beat(16)12
Avg EPS beat(16)5.48%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)2.1%
Revenue beat(4)3
Avg Revenue beat(4)0.77%
Min Revenue beat(4)-0.43%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)0.05%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.34%
PT rev (3m)5.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.18%
EPS NY rev (1m)1%
EPS NY rev (3m)1.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.1%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)2.56%
Valuation
Industry RankSector Rank
PE 32.1
Fwd PE 28.83
P/S 5.75
P/FCF 26.75
P/OCF 24.87
P/B 8.16
P/tB 8.34
EV/EBITDA 23.46
EPS(TTM)2.08
EY3.12%
EPS(NY)2.32
Fwd EY3.47%
FCF(TTM)2.5
FCFY3.74%
OCF(TTM)2.68
OCFY4.02%
SpS11.6
BVpS8.18
TBVpS8.01
PEG (NY)2.84
PEG (5Y)5.3
Graham Number19.57
Profitability
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROCE 19.43%
ROIC 14.18%
ROICexc 21.54%
ROICexgc 22.02%
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
FCFM 21.51%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-9.14%
OM growth 5Y-0.23%
PM growth 3Y-2.97%
PM growth 5Y-2.47%
GM growth 3Y0.68%
GM growth 5Y-0.51%
F-Score7
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.68%
Cap/Sales 1.63%
Interest Coverage 250
Cash Conversion 103.34%
Profit Quality 117.23%
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 8.25
F-Score7
WACC8.89%
ROIC/WACC1.6
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.89%
EPS 3Y2%
EPS 5Y6.06%
EPS Q2Q%6.52%
EPS Next Y11.32%
EPS Next 2Y11.05%
EPS Next 3Y9.4%
EPS Next 5YN/A
Revenue 1Y (TTM)4.21%
Revenue growth 3Y4.28%
Revenue growth 5Y7.79%
Sales Q2Q%4.54%
Revenue Next Year10.66%
Revenue Next 2Y9.32%
Revenue Next 3Y7.39%
Revenue Next 5YN/A
EBIT growth 1Y6.51%
EBIT growth 3Y-5.25%
EBIT growth 5Y7.55%
EBIT Next Year43.95%
EBIT Next 3Y16.08%
EBIT Next 5YN/A
FCF growth 1Y-19.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.27%
OCF growth 3YN/A
OCF growth 5YN/A

EXPONENT INC / EXPO Fundamental Analysis FAQ

What is the fundamental rating for EXPO stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXPO.


What is the valuation status of EXPONENT INC (EXPO) stock?

ChartMill assigns a valuation rating of 2 / 10 to EXPONENT INC (EXPO). This can be considered as Overvalued.


Can you provide the profitability details for EXPONENT INC?

EXPONENT INC (EXPO) has a profitability rating of 7 / 10.


What is the valuation of EXPONENT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EXPONENT INC (EXPO) is 32.1 and the Price/Book (PB) ratio is 8.16.


How sustainable is the dividend of EXPONENT INC (EXPO) stock?

The dividend rating of EXPONENT INC (EXPO) is 5 / 10 and the dividend payout ratio is 58.07%.